[1]Chan HL, Sung JJ.Hepatocellular carcinoma and hepatitis Bvirus[J].Semin Liver Dis, 2006, 26 (2) :153-161.
|
[2]Limquiaco JL, Wong GL, Wong VW, et al.Evaluation ofmodel for end stage liver disease (MELD) -based systemsas prognostic index for hepatocellular carcinoma[J].JGastroenterol Hepatol, 2009, 24 (1) :63-69.
|
[3]Liaw YF, Sung JJ, Chow WC, et al.Lamivudine for patientswith chronic hepatitis B and advanced liver disease[J].NEngl J Med, 2004, 351 (15) :1521-1531.
|
[4]Wong VW, Wong GL, Chim AM, et al.Surrogate end pointsand long-term outcome in patients with chronic hepatitisB[J].Clin Gastroenterol Hepatol, 2009, 7 (10) :1113-1120.
|
[5]Sung JJ, Tsoi KK, Wong VW, et al.Meta-analysis:Treatment ofhepatitis B infection reduces risk of hepatocellular carcinoma[J].Aliment Pharmacol Ther, 2008, 28 (9) :1067-1077.
|
[6]Wong GL, Wong VW, Tan GM, et al.Surveillance programmefor hepatocellular carcinoma improves the survival of patientswith chronic viral hepatitis[J].Liver Int, 2008, 28 (1) :79-87.
|
[7]Zhang BH, Yang BH, Tang ZY.Randomized controlled trialof screening for hepatocellular carcinoma[J].J Cancer ResClin Oncol, 2004, 130 (7) :417-422.
|
[8]Wong VW, Chan SL, Mo F, et al.Clinical scoring systemto predict hepatocellular carcinoma in chronic hepatitis Bcarriers[J].J Clin Oncol, 2010, 28 (10) :1660-1665.
|
[9]Mok TS, Yeo W, Yu S, et al.An intensive surveillanceprogram detected a high incidence of hepatocellularcarcinoma among hepatitis B virus carriers with abnormalalpha-fetoprotein levels or abdominal ultrasonographyresults[J].J Clin Oncol, 2005, 23 (31) :8041-8047.
|
[10]Chan HL, Hui AY, Wong ML, et al.Genotype C hepatitisB virus infection is associated with an increased risk ofhepatocellular carcinoma[J].Gut, 2004, 53 (10) :1494-1498.
|
[1] | Ru JIA, Pingping ZHANG, Yuan YUAN, Yiyang HU, Qin FENG. Differences and application value of plasma bile acids in tumors of the liver[J]. Journal of Clinical Hepatology, 2024, 40(10): 2042-2048. doi: 10.12449/JCH241018 |
[2] | YANG Xu, SUN WenBing, GAO Jun. Diagnosis and treatment of hepatic vascular tumors[J]. Journal of Clinical Hepatology, 2020, 36(11): 2569-2573. doi: 10.3969/j.issn.1001-5256.2020.11.039 |
[3] | WANG WenHui, DUAN XuHua, LI Hao, LI FengYao, JU ShuGuang, WANG ManZhou, REN JianZhuang, HAN XinWei. Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor[J]. Journal of Clinical Hepatology, 2020, 36(12): 2730-2734. doi: 10.3969/j.issn.1001-5256.2020.12.018 |
[4] | ZHANG ZhongLin, YUAN YuFeng. Key operating points of laparoscopic hepatectomy for liver tumor in difficult locations[J]. Journal of Clinical Hepatology, 2020, 36(12): 2663-2666. doi: 10.3969/j.issn.1001-5256.2020.12.006 |
[5] | Li ShanShan, Zhang Ke, Cheng ShuJie, Yang JiHong, Gao Feng, Li JingHua. Current status and future perspectives of the application of medical 3D visualization technology in accurate surgery of liver tumors[J]. Journal of Clinical Hepatology, 2019, 35(5): 1114-1117. doi: 10.3969/j.issn.1001-5256.2019.05.042 |
[6] | Wang ZhiYu, Gu SanWei, Chen XiaoQian, Cai YanJun. Clonorchiasis misdiagnosed as hepatic tumor: a case report[J]. Journal of Clinical Hepatology, 2018, 34(3): 602-603. doi: 10.3969/j.issn.1001-5256.2018.03.033 |
[7] | Chen WeiXia, Wang Lei, Liu Yang, Ji Guang, Xing LianJun. Expression of dendritic cell subsets in patients with different stages of chronic HBV infection:a comparative analysis[J]. Journal of Clinical Hepatology, 2017, 33(3): 458-461. doi: 10.3969/j.issn.1001-5256.2017.03.012 |
[8] | Lu NingNing, Sun Bin, Cui XiongWei, Long Jiang, Gao WenFeng, Zheng JiaSheng. Diagnosis and treatment of subcapsular hemorrhage after liver tumor ablation[J]. Journal of Clinical Hepatology, 2017, 33(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2017.12.014 |
[9] | Gao Rui, Liu ZhongJing, Chen Fei, Gao Lei, Jiang ChuanWu. Multivariate regression analysis of risk factors for HBV-related primary liver cancer[J]. Journal of Clinical Hepatology, 2014, 30(4): 370-372. doi: 10.3969/j.issn.1001-5256.2014.04.021 |
[10] | Xu XiuHua, Xiang XiaoXing, Long AiHua, Liu Dan, Wang JingSong. Differential distribution of age and HBV serological markers in liver cirrhosis and non-cirrhotic patients with primary liver cancer[J]. Journal of Clinical Hepatology, 2013, 29(3): 214-216. |
[11] | Chen MinHua. Standardization of thermal ablation in treatment of liver tumor[J]. Journal of Clinical Hepatology, 2013, 29(8): 561-563. doi: 10.3969/j.issn.1001-5256.2013.08.001 |
[12] | Jin WenWen, Xin YongNing, Dong QuanJiang, Zhao ShouFeng, Yu XinJuan, Jiang Man, Xu Jing, Xuan ShiYing. The preliminary study on the relationship between hepatitis B virus BCP gene mutations and HBV-related primary hepatocellular carcinoma in Qingdao[J]. Journal of Clinical Hepatology, 2012, 28(2): 130-134. |
[13] | Wang JiPing, Leng JiYan, Cui YaQiong, Zhang Li, Wang Yan. The diagnosis and clinical value of multi-slice spiral CT in children with common liver tumor[J]. Journal of Clinical Hepatology, 2011, 27(7): 718-721. |
[14] | Chen Hong, Wang Zhi, Wu Jian. Circulating tumor cells of hepatocellular carcinoma and their clinical implications[J]. Journal of Clinical Hepatology, 2011, 27(8): 796-800. |
[15] | Gao BaoHua, Wang Wen, Niu ChunYan, Zheng JianYun, Liu Bing, Luo JianMei. The expression of HMGB1 in hepatocellular carcinoma, paracancerous liver tissue and its significance[J]. Journal of Clinical Hepatology, 2011, 27(8): 850-853. |
[17] | Yang BiWei, Gan YuHong, Ye ShengLong, Zhang BoHeng, Ren ZhengGang, Xia JingLin, Wang YanHong, Ge NingLing, Chen Yi, Li LiXin, Le Fan, Zhang Lan. Necrosis range and safety of radiofrequency combined with systemic chemotherapy and radiofrequency alone.[J]. Journal of Clinical Hepatology, 2004, 20(6): 364-365. |